BRIEF published on 07/23/2026 at 17:50, 2 months 30 days ago AKWEL enregistre une baisse de chiffre d'affaires au 1er semestre 2026 Chiffre D'affaires Industrie Automobile Baisse 2026 AKWEL
BRIEF published on 07/23/2026 at 17:50, 2 months 30 days ago AKWEL Reports 18.7% Revenue Decline in H1 2026 Automotive Industry Revenue Decline Global Markets 2026 Forecast AKWEL
PRESS RELEASE published on 07/23/2026 at 17:45, 2 months 30 days ago AKWEL : chiffre d'affaires du 1er semestre 2026 AKWEL enregistre une baisse de -18,7% de son chiffre d'affaires au 1er semestre 2026 malgré une trésorerie nette de 98,1 M€. Perspectives de recul entre -12% et -15% pour l'année Chiffre D'affaires Perspectives Baisse Trésorerie Nette AKWEL
PRESS RELEASE published on 07/23/2026 at 17:45, 2 months 30 days ago AKWEL : first-half 2026 revenue AKWEL reports 18.7% revenue decline in H1 2026, with net cash position of €98.1 M. Outlook indicates expected revenue drop of -12% to -15% for full year 2026 Revenue Decline Outlook Net Cash Position Financial Year 2026 AKWEL
BRIEF published on 07/08/2026 at 17:50, 3 months 14 days ago Akwel : Détails sur les Actions et Droits de Vote au 30 Juin 2026 Droits De Vote Actions Auto-détention AKWEL 30 Juin 2026
BRIEF published on 07/08/2026 at 17:50, 3 months 14 days ago Akwel: Details on Shares and Voting Rights as of June 30, 2026 Voting Rights Actions Self-detention AKWEL June 30, 2026
PRESS RELEASE published on 07/08/2026 at 17:45, 3 months 14 days ago Akwel : nombre d'actions et droits de vote au 30.06.2026 Détails des droits de vote et actions de la société conformément à la réglementation financière en vigueur Autorité Des Marchés Financiers Droits De Vote Code De Commerce Actions Réglementation
BRIEF published on 06/11/2026 at 17:50, 4 months 11 days ago État des droits de vote et actions d'Akwel au 31 mai 2026 Droits De Vote Actions Transparence Financière AKWEL 31 Mai 2026
BRIEF published on 06/11/2026 at 17:50, 4 months 11 days ago Status of voting rights and shares of Akwel as of May 31, 2026 Voting Rights Shares Financial Transparency AKWEL May 31, 2026
PRESS RELEASE published on 06/11/2026 at 17:45, 4 months 11 days ago Akwel : nombre d'actions et droits de vote au 31.05.2026 Déclarations sur les droits de vote et actions d'Akwel conformément à la réglementation financière Droits De Vote Réglementation Financière Actions Déclarations AKWEL
Published on 10/23/2026 at 02:20, 5 hours 58 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 8 hours 48 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 9 hours 48 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 16 hours 18 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 17 hours 48 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 07:00, 1 hour 18 minutes ago EQS-Adhoc: BB Biotech AG publishes its interim report
Published on 10/23/2026 at 07:00, 1 hour 18 minutes ago ATOSS Software SE: Revenue growth and high profitability in the third quarter put ATOSS on track for another record year
Published on 10/23/2026 at 07:00, 1 hour 18 minutes ago BB Biotech Q3 2026: Positive returns, clinical progress and active portfolio redeployment
Published on 10/23/2026 at 06:45, 1 hour 33 minutes ago GURIT REPORTS SOLID THIRD-QUARTER PERFORMANCE AND REITERATES FULL-YEAR GUIDANCE
Published on 10/23/2026 at 07:00, 1 hour 18 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 14 hours 18 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 14 hours 18 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 14 hours 18 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
